Bloomage BioTechnology Corporation Statistics

Total Valuation

Bloomage BioTechnology Corporation has a market cap or net worth of CNY 31.21 billion. The enterprise value is 31.01 billion.

Market Cap	31.21B
Enterprise Value	31.01B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Aug 8, 2024

Share Statistics

Bloomage BioTechnology Corporation has 478.36 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class	n/a
Shares Outstanding	478.36M
Shares Change (YoY)	-0.01%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	0.72%
Owned by Institutions (%)	11.36%
Float	154.45M

Valuation Ratios

The trailing PE ratio is 71.63 and the forward PE ratio is 44.47.

PE Ratio	71.63
Forward PE	44.47
PS Ratio	5.50
PB Ratio	4.45
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.82, with an EV/FCF ratio of -260.59.

EV / Earnings	70.44
EV / Sales	5.41
EV / EBITDA	42.82
EV / EBIT	71.38
EV / FCF	-260.59

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.04.

Current Ratio	2.36
Quick Ratio	0.99
Debt / Equity	0.04
Debt / EBITDA	0.42
Debt / FCF	-2.54
Interest Coverage	59.86

Financial Efficiency

Return on equity (ROE) is 6.20% and return on invested capital (ROIC) is 3.74%.

Return on Equity (ROE)	6.20%
Return on Assets (ROA)	3.19%
Return on Capital (ROIC)	3.74%
Revenue Per Employee	1.23M
Profits Per Employee	94,560
Employee Count	4,655
Asset Turnover	0.67
Inventory Turnover	1.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.76% in the last 52 weeks. The beta is 0.84, so Bloomage BioTechnology Corporation's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-15.76%
50-Day Moving Average	56.42
200-Day Moving Average	59.02
Relative Strength Index (RSI)	59.85
Average Volume (20 Days)	6,192,857

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bloomage BioTechnology Corporation had revenue of CNY 5.73 billion and earned 440.18 million in profits. Earnings per share was 0.91.

Revenue	5.73B
Gross Profit	4.20B
Operating Income	434.40M
Pretax Income	527.86M
Net Income	440.18M
EBITDA	664.83M
EBIT	434.40M
Earnings Per Share (EPS)	0.91

Full Income Statement

Balance Sheet

The company has 541.55 million in cash and 302.03 million in debt, giving a net cash position of 239.52 million or 0.50 per share.

Cash & Cash Equivalents	541.55M
Total Debt	302.03M
Net Cash	239.52M
Net Cash Per Share	0.50
Equity (Book Value)	7.05B
Book Value Per Share	14.67
Working Capital	1.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 738.82 million and capital expenditures -857.81 million, giving a free cash flow of -118.99 million.

Operating Cash Flow	738.82M
Capital Expenditures	-857.81M
Free Cash Flow	-118.99M
FCF Per Share	-0.25

Full Cash Flow Statement

Margins

Gross margin is 73.25%, with operating and profit margins of 7.58% and 7.68%.

Gross Margin	73.25%
Operating Margin	7.58%
Pretax Margin	9.21%
Profit Margin	7.68%
EBITDA Margin	11.60%
EBIT Margin	7.58%
FCF Margin	-2.08%

Dividends & Yields

This stock pays an annual dividend of 0.38, which amounts to a dividend yield of 0.57%.

Dividend Per Share	0.38
Dividend Yield	0.57%
Dividend Growth (YoY)	-37.70%
Years of Dividend Growth	4
Payout Ratio	41.94%
Buyback Yield	0.01%
Shareholder Yield	0.58%
Earnings Yield	1.40%
FCF Yield	-0.38%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bloomage BioTechnology Corporation has an Altman Z-Score of 12.53.

Altman Z-Score	12.53
Piotroski F-Score	n/a